Posted by admin on Jul 15th, 2022

Bath & Body Works (NYSE:BBWI – Get Rating) was downgraded by research analysts at Evercore ISI from an “outperform” rating to an “in-line” rating in a research report issued to clients and investors on Wednesday, Marketbeat.com reports. They presently have a $28.00 price objective on the stock, down from their previous price objective of $60.00. Evercore ISI’s target price would indicate a potential upside of 7.86% from the stock’s previous close.

A number of other equities research analysts have also recently issued reports on BBWI. Raymond James began coverage on shares of Bath & Body Works in a report on Tuesday. They issued a “strong-buy” rating and a $45.00 target price on the stock. Piper Sandler began coverage on shares of Bath & Body Works in a report on Thursday, June 30th. They issued an “overweight” rating and a $58.00 target price on the stock. Deutsche Bank Aktiengesellschaft dropped their target price on shares of Bath & Body Works from $78.00 to $61.00 in a report on Thursday, May 19th. JPMorgan Chase & Co. cut shares of Bath & Body Works from an “overweight” rating to a “neutral” rating and lowered their price target for the company from $63.00 to $30.00 in a report on Wednesday, June 29th. Finally, Citigroup lowered their price target on shares of Bath & Body Works from $87.00 to $54.00 and set a “buy” rating on the stock in a report on Monday, May 23rd. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Bath & Body Works has an average rating of “Moderate Buy” and a consensus price target of $61.00.

Bath & Body Works stock opened at $25.96 on Wednesday. The firm has a 50-day moving average of $36.08 and a 200-day moving average of $47.74. Bath & Body Works has a one year low of $25.75 and a one year high of $82.00. The company has a market cap of $5.94 billion, a price-to-earnings ratio of 5.66, a P/E/G ratio of 1.79 and a beta of 1.72.

Bath & Body Works (NYSE:BBWI – Get Rating) last posted its quarterly earnings data on Wednesday, May 18th. The company reported $0.64 EPS for the quarter, topping analysts’ consensus estimates of $0.51 by $0.13. The company had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.43 billion. Bath & Body Works had a net margin of 15.41% and a negative return on equity of 69.03%. Analysts expect that Bath & Body Works will post 3.85 earnings per share for the current year.

In other Bath & Body Works news, CFO Wendy C. Arlin sold 6,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 19th. The shares were sold at an average price of $55.00, for a total value of $330,000.00. Following the sale, the chief financial officer now owns 98,888 shares in the company, valued at $5,438,840. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Thomas E. Mazurek sold 16,338 shares of the firm’s stock in a transaction that occurred on Friday, May 27th. The shares were sold at an average price of $42.25, for a total transaction of $690,280.50. Following the completion of the sale, the insider now owns 11,225 shares in the company, valued at approximately $474,256.25. The disclosure for this sale can be found here. Company insiders own 0.37% of the company’s stock.

A number of institutional investors have recently modified their holdings of BBWI. Prospera Financial Services Inc acquired a new stake in Bath & Body Works in the first quarter valued at approximately $25,000. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Bath & Body Works by 119.7% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 525 shares of the company’s stock worth $26,000 after purchasing an additional 286 shares during the period. EverSource Wealth Advisors LLC lifted its holdings in shares of Bath & Body Works by 490.9% during the first quarter. EverSource Wealth Advisors LLC now owns 585 shares of the company’s stock worth $28,000 after purchasing an additional 486 shares during the period. Acadian Asset Management LLC acquired a new position in shares of Bath & Body Works during the fourth quarter worth $30,000. Finally, First Horizon Advisors Inc. lifted its holdings in shares of Bath & Body Works by 361.4% during the first quarter. First Horizon Advisors Inc. now owns 646 shares of the company’s stock worth $31,000 after purchasing an additional 506 shares during the period. Hedge funds and other institutional investors own 97.11% of the company’s stock.

Bath & Body Works Company Profile (Get Rating)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.

Zurcher Kantonalbank Zurich Cantonalbank Has $479,000 Stock Holdings in F.N.B. Co. (NYSE:FNB)

Cosan (NYSE:CSAN) PT Lowered to $15.60